Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Differences between influenza and COVID-19 patients who required hospitalization: A study of the 2024-2025 season
Naoyuki Miyashita1, Yasushi Nakamori2, Makoto Ogata1
1First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Background:
During the winter and spring of 2024-2025, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XEC subvariant became the main cause of the epidemic, and at the same time, major influenza epidemics were also observed. To clarify the differences between COVID-19 and influenza, we conducted a comparative study of patients who required hospitalization during the same period.
Methods:
We compared 193 patients with COVID-19 Omicron XEC subvariant and 98 patients with influenza H1N1 pdm09 who required hospitalization.
Results:
The following characteristics were significantly more common in the COVID-19 group than in the influenza group: 1) males, 2) patients with chronic kidney disease, malignant tumors, autoimmune diseases, and patients using immunosuppressants, 3) patients with multiple underlying diseases, 4) healthcare-associated pneumonia, 5) pure viral pneumonia, 6) aspiration pneumonia, 7) cases in which antivirals had not been used since the diagnosis of infection, 8) patients who required invasive mechanical ventilation management or intensive care unit admission, and 9) deaths. On the other hand, the following characteristics were significantly more frequently observed in the influenza group than in the COVID-19 group: 1) patients without underlying diseases, 2) patients who had been vaccinated within the past year, 3) community-acquired pneumonia, and 4) mixed bacterial pneumonia.
Conclusions:
There were many differences between the COVID-19 group and the influenza group that required hospitalization. The rates of severe illness and mortality in the elderly remain high in the COVID-19 group.
Related Concept Videos
Vaccinations
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Leaky Scanning
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Stages of Infection

